Nysa Biomed Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -79.04%
(FY 2022)
- Profit 4444.52%
(FY 2022)
- Net Worth 412.27%
(FY 2022)
- Total Assets 1027.45%
(FY 2022)
About Nysa Biomed
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yatin Doshi and Supriya Doshi serve as directors at the Company.
- CIN/LLPIN
U24290PN2020PTC190741
- Company No.
190741
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nysa Biomed?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yatin Doshi  | Managing Director | 05-May-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Supriya Doshi | Director | 05-May-2020 | Current |
Financial Performance of Nysa Biomed.
Nysa Biomed Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 79.04% decrease. The company also saw a substantial improvement in profitability, with a 4444.52% increase in profit. The company's net worth Soared by an impressive increase of 412.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nysa Biomed?
In 2022, Nysa Biomed had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ahaan Healthcare Private LimitedActive 17 years 1 monthYatin Doshi and Supriya Doshi are mutual person
- Niya Healthcare Private LimitedActive 18 years 8 months
Yatin Doshi and Supriya Doshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nysa Biomed?
Nysa Biomed has a workforce of 36 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nysa Biomed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nysa Biomed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
